Switch theme
Sign up to access all valuation multiples
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurusā clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with internationalĀ pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.
2004
213
LTM Revenue $213M
LTM EBITDA $66.8M
$3.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Camurus has a last 12-month revenue of $213M and a last 12-month EBITDA of $66.8M.
In the most recent fiscal year, Camurus achieved revenue of $185M and an EBITDA of $56.4M.
Camurus expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Camurus valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $170M | $185M | XXX | XXX | XXX |
| Gross Profit | $84.7M | $158M | XXX | XXX | XXX |
| Gross Margin | 50% | 85% | XXX | XXX | XXX |
| EBITDA | $56.1M | $56.4M | XXX | XXX | XXX |
| EBITDA Margin | 33% | 30% | XXX | XXX | XXX |
| Net Profit | $5.5M | $42.8M | XXX | XXX | XXX |
| Net Margin | 3% | 23% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Camurus's stock price is SEK 562 (or $56).
Camurus has current market cap of SEK 33.1B (or $3.3B), and EV of SEK 30.3B (or $3.0B).
See Camurus trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.0B | $3.3B | XXX | XXX | XXX | XXX | $0.96 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Camurus has market cap of $3.3B and EV of $3.0B.
Camurus's trades at 14.1x LTM EV/Revenue multiple, and 45.0x LTM EBITDA.
Analysts estimate Camurus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Camurus and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.0B | XXX | XXX | XXX |
| EV/Revenue | 16.2x | XXX | XXX | XXX |
| EV/EBITDA | 53.2x | XXX | XXX | XXX |
| P/E | 77.2x | XXX | XXX | XXX |
| P/E/Growth | 0.8x | XXX | XXX | XXX |
| EV/FCF | 84.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCamurus's NTM/LTM revenue growth is 48%
Camurus's revenue per employee for the last fiscal year averaged $0.9M, while opex per employee averaged $0.6M for the same period.
Over next 12 months, Camurus's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Camurus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Camurus and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 1% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 78% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.9M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.6M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 26% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 68% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Camurus acquired XXX companies to date.
Last acquisition by Camurus was XXXXXXXX, XXXXX XXXXX XXXXXX . Camurus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Camurus founded? | Camurus was founded in 2004. |
| Where is Camurus headquartered? | Camurus is headquartered in Sweden. |
| How many employees does Camurus have? | As of today, Camurus has 213 employees. |
| Who is the CEO of Camurus? | Camurus's CEO is Mr. Fredrik Tiberg. |
| Is Camurus publicy listed? | Yes, Camurus is a public company listed on STO. |
| What is the stock symbol of Camurus? | Camurus trades under CAMX ticker. |
| When did Camurus go public? | Camurus went public in 2015. |
| Who are competitors of Camurus? | Similar companies to Camurus include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Camurus? | Camurus's current market cap is $3.3B |
| What is the current revenue of Camurus? | Camurus's last 12-month revenue is $213M. |
| What is the current EBITDA of Camurus? | Camurus's last 12-month EBITDA is $66.8M. |
| What is the current EV/Revenue multiple of Camurus? | Current revenue multiple of Camurus is 14.1x. |
| What is the current EV/EBITDA multiple of Camurus? | Current EBITDA multiple of Camurus is 45.0x. |
| What is the current revenue growth of Camurus? | Camurus revenue growth between 2023 and 2024 was 9%. |
| Is Camurus profitable? | Yes, Camurus is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
